AI News

    It’s not easy to get depression-detecting AI through the FDA

    For the past seven years, the California-based startup Kintsugi has been developing AI designed to detect signs of depression and anxiety from a person's speech. But after failing to secure FDA clearance in time, the company is shutting down and releasing most of its technology a...

    TVA

    The Verge AI

    Source

    It’s not easy to get depression-detecting AI through the FDA
    AI Analysis

    Generated insight by OnAirToday AI

    Developing AI for sensitive health conditions like depression faces significant regulatory hurdles, as demonstrated by Kintsugi's struggle to gain FDA approval. This failure highlights the complex pathway for bringing AI-driven mental health tools from research to accessible clinical application.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at The Verge AI →

    Get the day's AI news in one short email. Free.

    Share
    Filed under:AI News

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000

    Subscribe to our Free AI Newsletter

    The Daily AI Digest, every morning. Pick your topics after you subscribe.

    Free. Unsubscribe anytime.